Skip to content
HeyJared

Willing To Win - Biotech Leaders Against All Odds

Willing to Win — Biotech Leaders Against All Odds. Long-form conversations with biotech founders, CEOs and Chairpersons who have built companies through real adversity: failed trials, board fights, near-bankruptcy, regulatory setbacks, personal cost. Not the highlight reel.

YouTube · Official site

Indexed videos, last 90 days
26
Latest publication
Sep 22, 2026
Audience
~55 subscribers
Earliest in this view
Jul 21, 2026

Latest videos

  1. Video · Sep 22, 2026

    "Someone else will drive it for you" | HTGF Managing Director Achim Plum (opens the original)

    Excerpt · 0 min · 70 views by Sep 30, 2026

    Read excerpt

    When an investor decides a company has outgrown its CEO, the talk happens at a conference, over a couple of drinks. His version of it: raise your hand now and drive the leadership question yourself, or watch someone else drive it. He has sat on both sides of that conversation. Achim Plum spent 25 years in biotech operating roles, went through two IPOs, and is now a Managing Director at High-Tech Gruenderfonds (HTGF), Germany's most active seed investor. Full conversation with Christian Rados on

  2. Video · Sep 21, 2026

    "We are blind, we don't invest" | HTGF Managing Director Achim Plum (opens the original)

    Excerpt · 1 min · 126 views by Sep 30, 2026

    Read excerpt

    Follow-on decisions at HTGF happen in portfolio reviews, and a silent CEO can end the discussion in one sentence. His advice is to bring problems up early, with an analysis and possible solutions attached, because bad news you sit on surfaces anyway. Achim Plum heads life sciences and chemistry as a Managing Director at High-Tech Gruenderfonds (HTGF), Germany's most active seed investor with around 400 companies in the current portfolio. Full conversation with Christian Rados on Willing to Win,

  3. Video · Sep 19, 2026

    The unicorn they almost missed | HTGF Managing Director Achim Plum (opens the original)

    Excerpt · Neutral tone · 0 min · 128 views by Sep 30, 2026

    Read excerpt

    One pitch almost went out in the weekly deal-flow screening at HTGF. The company needed very little capital, reached a unicorn exit, and became the fund's best returner, with HTGF still holding a decent stake. Achim Plum is a Managing Director at High-Tech Gruenderfonds (HTGF), Germany's most active seed investor, which has invested in around 800 companies. Full conversation with Christian Rados on Willing to Win, Episode 22 #biotech #founder #podcast Willing to Win biotech biotech podcast found

  4. Video · Sep 18, 2026

    "I want to be the most stupid one" | HTGF Managing Director Achim Plum (opens the original)

    Excerpt · 0 min · 67 views by Sep 30, 2026

    Read excerpt

    He spent 25 years in biotech operating roles and went through two IPOs before switching to the investor side. Today he screens founder teams at HTGF against the mistakes he made himself. Achim Plum is a Managing Director at High-Tech Gruenderfonds (HTGF), Germany's most active seed investor, where he heads life sciences and chemistry. Full conversation with Christian Rados on Willing to Win, Episode 22 #biotech #founder #podcast Willing to Win biotech biotech podcast founder podcast

  5. Video · Sep 17, 2026

    Episode 22 | So, Do We Have a Deal? (Achim Plum, HTGF) (opens the original)

    Excerpt · 52 min · 49 views by Sep 30, 2026

    Read excerpt

    Achim Plum spent 25 years on the operator side of biotech. Two IPOs, one of them closed on the last day of the roadshow, sitting at a Zurich breakfast with no idea whether the book would fill by evening. His last company died on the science itself. Then he switched sides. Since January 2025 he runs HTGF, Germany's most active seed investor, as the Managing Director heading Life Science and Chemistry. Around 400 companies in the portfolio, roughly 800 invested in since the fund started, a new 500

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

~55 subscribers

Measured Sep 19, 2026

Source's subscribers, not the number who saw an individual piece.

How this was measured

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about Willing To Win - Biotech Leaders Against All Odds